The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
Abstract
Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas the MS may play a limited role in accelerating atherosclerotic progression, it may significantly increase the risk of vascular events through prothrombotic or inflammatory mechanisms.29 -31”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [31]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239
(1989) · PubMed · Cited by 3,139
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387
Siedel, J., Hägele, E., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915
Fibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 594
Kannel, W. B., D’Agostino, R. B., & Belanger, A. J. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90063-9 · Cited by 466
Meade, T. W., Imeson, J., & Stirling, Y. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92556-6 · Cited by 432
Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial Infarction
Chalmers, T. C., Matta, R. J., Smith, H., & Kunzler, A.-M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711172972004 · Cited by 423
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.
Meade, T. W., Chakrabarti, R., Haines, A., North, W. R. S., & Stirling, Y. (1979) · BMJ · doi:10.1136/bmj.1.6157.153 · Cited by 410
Plasma fibrinogen--a major coronary risk factor.
Stone, M. C., & Thorp, J. M. (1985) · PubMed · Cited by 358
Balleisen, L., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657877 · Cited by 345
Nägele, U., Hägele, E., Sauer, G., Wiedemann, E., Lehmann, P., Wahlefeld, A. W., & Gruber, W. (1984) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1984.22.2.165 · Cited by 313
OOLOFESSON, B. O., Dahlén, G., & Nilsson, T. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059384 · Cited by 225
Miller, G. J., Martin, J., Webster, J., Wilkes, H., Miller, N. E., Wilkinson, W. H., & Meade, T. W. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90174-7 · Cited by 217
Blood rheology in arterial disease
Lowe, G. D. O. (1986) · Clinical Science · doi:10.1042/cs0710137 · Cited by 214
Fibrinogen: a possible link between social class and coronary heart disease.
Markowe, H. L. J., Marmot, M. G., Shipley, M. J., Bulpitt, C., Meade, T. W., Stirling, Y., Vickers, M. V., & Semmence, A. (1985) · BMJ · doi:10.1136/bmj.291.6505.1312 · Cited by 205
Plasma fibrinogen and coronary risk factors: The Scottish heart health study
Lee, A. J., Smith, W. C. S., Lowe, G. D. O., & Tunstall-Pedoe, H. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90075-z · Cited by 200
Papp, A. C., Hatzakis, H., Bracey, A., & Wu, K. K. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646519 · Cited by 182
Self-citation4 Fibrinogen, Fibrin and Fibrin Degradation Products in Relation to Atherosclerosis
Smith, E. B. (1986) · Clinics in Haematology · doi:10.1016/s0308-2261(18)30021-3 · Cited by 163
Measuring plasma fibrinogen to predict stroke and myocardial infarction.
Minno, G. D., & Mancini, M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.1.1 · Cited by 162
Physical Conditioning Augments the Fibrinolytic Response to Venous Occlusion in Healthy Adults
Williams, R. S., Logue, E. E., Lewis, J. L., Barton, T., Stead, N. W., Wallace, A. G., & Pizzo, S. V. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021802 · Cited by 151
Rosengren, A., Wilhelmsen, L., Welin, L., Tsipogianni, A., Teger‐Nilsson, A. ‐., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.300.6725.634 · Cited by 148
Plasma fibrinogen and ischemic heart disease risk factors.
Møller, L., & Kristensen, T. S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.344 · Cited by 131
Mitropoulos, K. A., Miller, G. J., Reeves, B. E. A., Wilkes, H., & Cruickshank, J. K. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90104-4 · Cited by 119
Ritchie, D. G., Levy, B., Adams, M. A., & Fuller, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1530 · Cited by 118
Stamler, J., Berkson, D. M., Lindberg, H. A., Hall, Y., Miller, W. A., Mojonnier, L., Levinson, M. J., Cohen, D. B., & Young, Q. D. (1966) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33232-1 · Cited by 118
Increased Neutrophil Elastase Activity in Cigarette Smokers
Weitz, J. I., CROWLEY, K. A., LANDMAN, S. L., LIPMAN, B. I., & YU, J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-680 · Cited by 114
Balleisen, L., Assmann, G., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1660106 · Cited by 114
YARNELL, J. W. G., Sweetnam, P. M., Rogers, S., Elwood, P. C., Bainton, D., Baker, I. A., Eastham, R. D., O’Brien, J. R., & Etherington, M. D. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.8.909 · Cited by 113
The effect of physiological levels of fibrinogen on platelet aggregation
Meade, T. W., Vickers, M. V., Thompson, S. G., & Seghatchian, M. J. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90185-9 · Cited by 104
Short-term intraindividual variability in hemostasis factors the ARIC study
Chambless, L. E., McMahon, R. P., Wu, K. K., Folsom, A. R., Finch, A., & Shen, Y.-L. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90017-k · Cited by 99
Self-citationBaker, I. A., Eastham, R. D., Elwood, P. C., Etherington, M. D., O'Brien, J. R., & Sweetnam, P. M. (1982) · Heart · doi:10.1136/hrt.47.5.490 · Cited by 79
Relationship between sex hormones and haemostatic factors in healthy middle-aged men
Bonithon‐Kopp, C., Scarabin, P., Bara, L., Castanier, M., Jacqueson, A., & Roger, M. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90303-6 · Cited by 76
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
Skartlien, A. H., Lyberg-Beckmann, S., Holme, I., Hjermann, I., & Prydz, H. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.798 · Cited by 75
Blood Coagulation and Fibrinolysis in a Random Sample of 788 Men 54 Years Old
Korsan-Bengtsen, K., Wilhelmsen, L., & Tibblin, G. (1972) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649045 · Cited by 64
Conjugated equine oestrogens and blood clotting: a follow-up report.
Poller, L., THOMSON, J. M., & Coope, J. (1977) · BMJ · doi:10.1136/bmj.1.6066.935 · Cited by 59
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90176-8 · Cited by 56
Acute changes in Atherogenic and Thrombogenic Factors with Cessation of Smoking
Feher, M. D., RAMPLING, M. W., Brown, J., Robinson, R., Richmond, W., Cholerton, S., Bain, B. J., & Sever, P. S. (1990) · Journal of the Royal Society of Medicine · doi:10.1177/014107689008300306 · Cited by 51
Factor VII activation and menopausal status
Scarabin, P., Bonithon‐Kopp, C., Bara, L., Malméjac, A., Guize, L., & Samama, M. M. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90322-4 · Cited by 50
The contribution of leukocyte proteases to fibrinolysis
Plow, E. F. (1986) · Annals of Hematology · doi:10.1007/bf00320577 · Cited by 41
Wilkes, H., Kelleher, C. C., & Meade, T. W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90398-4 · Cited by 40
Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.
Yarnell, J. W. G., FEHILY, A. M., Milbank, J., Kubicki, A. J., Eastham, R. D., & Hayes, T. M. (1983) · Journal of Epidemiology & Community Health · doi:10.1136/jech.37.2.137 · Cited by 38
Gurewich, V., Lipiński, B., & Hyde, E. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648080 · Cited by 37
Miller, G. J., Seghatchian, M. J., Walter, S. J., Howarth, D., Thompson, S. G., ESNOUF, M. P., & Meade, T. W. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb02941.x · Cited by 34
Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
Mann, K. G. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.783 · Cited by 28
Effect of weight loss on coagulation factors VII and X
Baron, J. A., Mann, J. I., & Stukel, T. A. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90432-3 · Cited by 22
Cited by
Sorted by citations
Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J. (1999) · BMJ · doi:10.1136/bmj.319.7224.1523 · Cited by 1,360
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805
Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 730
Self-citationPlasma proteomic signature of age in healthy humans
Tanaka, T., Biancotto, A., Moaddel, R., Moore, A. Z., Gonzalez‐Freire, M., Aon, M. A., Candia, J., Zhang, P., Cheung, F., Fantoni, G., et al. (2018) · Aging Cell · doi:10.1111/acel.12799 · Cited by 562
Woodhouse, P. R., Khaw, K., Plummer, M., Meade, T. W., & Foley, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92689-1 · Cited by 553
Metadata
- Authors
- FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M.
- Affiliations
- University of Minnesota (US)
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- Corresponding author
- FOLSOM, A
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 91
- Issue
- 3
- Pages
- 191-205
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2001322531
- Cited by
- 321
- References
- 52
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 6
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC-55018, N01-HC55016, N01‐HC‐55015)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- fibrinogen, factor VII coagulant activity, cardiovascular risk factors, cardiovascular disease, Atherosclerosis Risk in Communities Study, sex differences, racial differences, modifiable lifestyle factors, smoking, alcohol consumption, physical activity, diabetes mellitus, insulin, lipoprotein(a), LDL cholesterol, HDL cholesterol, triglycerides, menopause, white blood cell count, aging
- MeSH terms
- Body Constitution, Cardiovascular Diseases, Coronary Disease, Factor VII, Female, Fibrinogen, Humans, Life Style, Lipids, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Factors, Smoking, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review